Skip to main content
. 2020 Apr 27;51(11):1076–1086. doi: 10.1111/apt.15730

Figure 1.

Figure 1

Unadjusted cumulative drug survival of tioguanine‐ and low dose thiopurine and allopurinol‐ (LDTA) treated IBD patients after 104 weeks of follow‐up